Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial.

Devetten, M P

Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial. [electronic resource] - Bone marrow transplantation Oct 2004 - 577-80 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0268-3369

10.1038/sj.bmt.1704642 doi


Acute Disease
Adult
Antineoplastic Agents, Alkylating--administration & dosage
Combined Modality Therapy
Female
Graft vs Host Disease--mortality
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Leukemia, Myeloid--drug therapy
Male
Middle Aged
Radiation Dosage
Recurrence
Retrospective Studies
Survival Analysis
Thiotepa--administration & dosage
Transplantation Conditioning
Transplantation, Homologous
Whole-Body Irradiation